Frontlight ResearchEarly access
Metastatic breast cancer trials in Germany
5 of 52 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peoplePROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan
- Where
- Amberg, Ansbach, Apolda, Aschaffenburg, Augsburg, Baden-Baden, Bad Reichenhall, Balingen, Bamberg, Berlin, Bielefeld, Bonn, Brandenburg an der Havel, Braunschweig, Bremen, Bremerhaven, Coburg, Dessau, Donauwörth, Dortmund, Dresden, Düsseldorf, Eggenfelden, Erfurt, Essen, Filderstadt - Bonlanden, Frankfurt, Freudenstadt, Fürstenfeldbruck, Fürstenwalde, Gerlingen, Giessen, Halle, Hamburg, Hanover, Hansestadt Salzwedel, Heidenheim, Heilbronn, Hildesheim, Homburg/Saar, Jena, Kaiserslautern, Karlsruhe, Kassel, Kempten, Kiel, Krefeld, Kulmbach, Landshut, Leer, Leipzig, Loerrach, Lübeck, Lüneburg, Magdeburg, Mainz, Marburg, Memmingen, Mönchengladbach, Mühlhausen, München, Mutlangen, Neumarkt, Neuruppin, Neustadt am Rübenberge, Nordhausen, Nuremberg, Oldenburg, Oranienburg, Potsdam, Recklinghausen, Regensburg, Rosenheim, Rotenburg (Wümme), Saalfeld, Saarbrücken, Schwäbisch Hall, Siegen, Singen, Solingen, Stade, Stuttgart, Torgau, Troisdorf, Ulm, Walsrode, Weiden, Weinheim, Wessenfels, Westerstede, Wiesbaden, Winnenden, Witten, Wolfsburg, Wuppertal, Würzburg, Zittau
- Age
- 18 years to 130 years
- People
- 800
- Run by
- AstraZeneca
See details and how to joinNCT05573893 - No phaseTaking peopleEORTC Metastatic Breast Cancer Module Development
- Where
- Berlin, Wuppertal
- Age
- 18 years and over
- People
- 568 worldwide
- Run by
- University of Leeds
See details and how to joinNCT07806266 - No phaseTaking peopleElacestrant in Patients With ER+ HER2- ESR1-mutated Locally Advanced or Metastatic Breast Cancer
- Where
- Freiburg im Breisgau, Paderborn, Ravensburg
- Age
- 18 years and over
- People
- 500
- Run by
- iOMEDICO AG
See details and how to joinNCT07563595 - No phaseTaking peoplePraegnant Breast Cancer: Early/Advanced/Metastatic
- Where
- Aachen, Amberg, Ansbach, Augsburg, Bamberg, Bayreuth, Berlin, Böblingen, Bonn, Bottrop, Chemnitz, Darmstadt, Deggendorf, Donauwörth, Dresden, Düsseldorf, Eggenfelden, Erlangen, Essen, Frankfurt am Main, Freiburg im Breisgau, Fürstenwalde, Fürth, Georgsmarienhütte, Halle, Hamburg, Heidelberg, Herne, Hösbach, Kaiserslautern, Karlsruhe, Kassel, Kiel, Koblenz, Langen, Leer, Leipzig, Lübeck, Mannheim, Mayen, München, Neuruppin, Nürtingen, Ostfildern, Paderborn, Recklinghausen, Regensburg, Rüdersdorf, Stralsund, Torgau, Tübingen, Ulm, Wetzlar, Würselen, Würzburg
- Age
- 18 years to 99 years
- People
- 13,500
- Run by
- University Hospital Tuebingen
See details and how to joinNCT02338167 - No phaseTaking peopleCATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer
- Where
- Augsburg, Berlin, Cologne, Dresden, Erlangen, Essen, Heidelberg, Regensburg, Stuttgart, Tübingen, Ulm, Würzburg
- Age
- 14 years to 100 years
- People
- 5,000
- Run by
- German Cancer Research Center
See details and how to joinNCT05652569